Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes

J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1643-1646. doi: 10.1016/j.jaip.2019.03.006. Epub 2019 Mar 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Anti-Asthmatic Agents / therapeutic use*
  • Asthma / blood
  • Asthma / drug therapy*
  • Asthma / physiopathology
  • Eosinophilia / blood
  • Eosinophilia / drug therapy*
  • Eosinophils
  • Female
  • Forced Expiratory Volume
  • Humans
  • Leukocyte Count
  • Male
  • Middle Aged
  • Omalizumab / therapeutic use*
  • Prognosis
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Anti-Asthmatic Agents
  • Omalizumab